LLY

911.3

-2.79%↓

JNJ

187.72

+0.89%↑

UNH

315.55

-2.81%↓

NVS

126.73

+0.5%↑

ABT

126.27

+1.64%↑

LLY

911.3

-2.79%↓

JNJ

187.72

+0.89%↑

UNH

315.55

-2.81%↓

NVS

126.73

+0.5%↑

ABT

126.27

+1.64%↑

LLY

911.3

-2.79%↓

JNJ

187.72

+0.89%↑

UNH

315.55

-2.81%↓

NVS

126.73

+0.5%↑

ABT

126.27

+1.64%↑

LLY

911.3

-2.79%↓

JNJ

187.72

+0.89%↑

UNH

315.55

-2.81%↓

NVS

126.73

+0.5%↑

ABT

126.27

+1.64%↑

LLY

911.3

-2.79%↓

JNJ

187.72

+0.89%↑

UNH

315.55

-2.81%↓

NVS

126.73

+0.5%↑

ABT

126.27

+1.64%↑

Search

West Pharmaceutical Services Inc

Open

SectorHealthcare

268.69 -4.42

Overview

Share price change

24h

Current

Min

263.68

Max

281.09

Key metrics

By Trading Economics

Income

8.2M

140M

Sales

38M

804M

P/E

Sector Avg

41.51

77.256

EPS

1.96

Dividend yield

0.3

Profit margin

17.406

Employees

10,600

EBITDA

17M

215M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+22.6% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.30%

2.33%

Next Dividend date

19 Nov 2025

Next Ex Dividend date

12 Nov 2025

Market Stats

By TradingEconomics

Market Cap

361M

20B

Previous open

273.11

Previous close

268.69

News Sentiment

By Acuity

50%

50%

174 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Past performance is not a reliable indicator of future results.

Related News

6 Nov 2025, 23:38 UTC

Earnings

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

6 Nov 2025, 23:00 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

6 Nov 2025, 22:19 UTC

Earnings
Major Market Movers

Block Shares Slide After 3Q Results Miss Estimates

6 Nov 2025, 21:53 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

6 Nov 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Sales $476M >WPM

6 Nov 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

6 Nov 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 Nov 2025, 23:45 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stocks Drop

6 Nov 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q EPS 80.7c >WPM

6 Nov 2025, 23:38 UTC

Market Talk

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

6 Nov 2025, 23:15 UTC

Earnings

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

6 Nov 2025, 23:14 UTC

Earnings

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

6 Nov 2025, 23:14 UTC

Earnings

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

6 Nov 2025, 23:13 UTC

Earnings

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

6 Nov 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

6 Nov 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

6 Nov 2025, 23:07 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

6 Nov 2025, 23:07 UTC

Earnings

Suzano 3Q Rev BRL12.2B >SUZ

6 Nov 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

6 Nov 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

6 Nov 2025, 22:45 UTC

Acquisitions, Mergers, Takeovers

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

6 Nov 2025, 22:25 UTC

Acquisitions, Mergers, Takeovers

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

6 Nov 2025, 22:13 UTC

Earnings

Fairfax Financial 3Q Rev $8.27B >FFH.T

6 Nov 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Sales $632.2M >CENX

6 Nov 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Adj EPS 56c >CENX

6 Nov 2025, 21:53 UTC

Earnings

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

6 Nov 2025, 21:52 UTC

Acquisitions, Mergers, Takeovers

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

6 Nov 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

6 Nov 2025, 21:50 UTC

Market Talk
Earnings
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

6 Nov 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

West Pharmaceutical Services Inc Forecast

Price Target

By TipRanks

22.6% upside

12 Months Forecast

Average 347.63 USD  22.6%

High 375 USD

Low 311 USD

Based on 10 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

213.26 / 219.27Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

174 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat